Introduction {#s02}
============

Inflammasomes are multimeric complexes formed in response to a variety of physiological and pathogenic stimuli. Inflammasome activation is an essential component of the innate immune response and is critical for the clearance of pathogens or damaged cells. However, overt inflammasome activation is also a major driver of autoimmune and metabolic disorders, underlying the importance of understanding this process in physiological and pathological contexts.

The inflammasome sensors are grouped according to their structural features into nucleotide-binding domain--like receptors (NLRs), absent in melanoma 2--like receptors (ALRs), and the recently identified pyrin. These receptors have the ability to assemble inflammasomes and activate the cysteine protease caspase-1. In addition to the sensor (NLR, ALR, or pyrin) and enzymatic component (caspase-1), most inflammasomes also use an adaptor molecule known as ASC (apoptosis-associated speck-like protein containing a caspase activation and recruitment domain). Upon detecting specific stimuli, the activated sensor nucleates ASC to form a discrete foci, or "speck," within the activated cell. Nucleated ASC sequentially recruits caspase-1, which undergoes proximity induced autocatalytic cleavage to produce the active subunits p10 and p20. These active caspase-1 subunits can then proteolytically process cytokines, IL-1β and IL-18, and induce a specific form of inflammatory cell death termed pyroptosis. Activated caspase-1 thus provides the host cell with dual defense mechanisms through the release of mature cytokines and removal of the infected or damaged cell. Inflammasome assembly is thus a coordinated signaling event essential for mounting an appropriate immune response after pathogenic or sterile insults. Although most studies have used in vitro culture systems and reconstitution assays to analyze inflammasome activation, recent advances have allowed visualization of these processes in vivo after an infectious insult at the level of a single cell ([@bib129]). Recent studies have also highlighted the existence of an NLRP3 inflammasome pathway, mediated by caspase-11 ([@bib69]).

Inflammasome activation is tightly regulated to provide defense against pathogenic insults and avoid damage to the host. Multiple molecular and cellular signals are therefore involved in maintaining the balance between inflammatory response and resolution. In this review, we provide an overview of the cellular and molecular mechanisms involved in the regulation of inflammasome activation.

NLR family {#s03}
==========

NLR family members all share a central nucleotide-binding domain (NBD), and most members have a C-terminal leucine-rich repeat (LRR) domain and a variable N-terminal domain. The NLR family can be subdivided into NLRP or NLRC based on whether the N terminus contains a pyrin or caspase activation and recruitment domain (CARD), respectively. Certain members of the family, including NLRP1, NLRP3, and NLRC4, have been well established as NLRs capable of forming inflammasomes, whereas other members, like NLRP6 and NLRP12, are still considered putative inflammasome sensors. It remains to be seen if other members of the NLR family are capable of forming or regulating inflammasome assembly in response to some unknown stimuli.

NLRP1 {#s04}
=====

NLRP1 was the first cytosolic receptor identified for its ability to form a caspase-1 activating platform ([@bib95]). Human NLRP1 contains the canonical NBD and LRR domains, a pyrin domain (PYD), as well as a function-to-find and a C-terminal CARD domain. The mouse genome encodes three paralogs, NLRP1(a--c), which all lack the PYD. NLRP1b is activated by anthrax lethal toxin produced by *Bacillus anthrax*. Lethal toxin comprises protective antigen and lethal factor; protective antigen generates pores in the host cell membrane, whereas lethal factor enters the cell and cleaves NLRP1b at an N-terminal site, leading to the induction of inflammasome activation ([Fig. 1](#fig1){ref-type="fig"}; [@bib14]). This cleavage is essential and sufficient to induce NLRP1b activation ([@bib14]). Proteolytic cleavage within the NLRP1b function-to-find domain is also required for assembly of a functional inflammasome ([@bib39]). Based on these observations, it has been hypothesized that NLRP1b could act as a sensor of protease activity caused by various bacterial toxins, although this has not been rigorously tested or shown. NLRP1b activation also promotes parasite clearance and provides protection against mortality in response to *Toxoplasma gondii* infection in mice ([@bib42]). *Toxoplasma*-induced NLRP1 activation is observed in susceptible rat strains ([@bib19]) and is a major determinant of parasite control in infected macrophages ([@bib12]), although activation of NLRP1b through this parasite does not result in detectable levels of an NLRP1b cleavage product ([@bib31]). This suggests that either NLRP1b processing is not a prerequisite for inflammasome activation as posited or a thorough analysis for a potentially unstable cleavage product is required to reconcile this discrepancy. The link between immune response to *Toxoplasma* infection and NLRP1 inflammasome is clinically relevant even in humans, as congenital toxoplasmosis is associated with single-nucleotide polymorphisms in the *NLRP1* gene and loss of NLRP1 in human monocytic cell lines promotes *Toxoplasma* infectivity ([@bib151]).

![**Canonical inflammasomes NLRP1, NLRP3, NLRC4, AIM2, and pyrin.** Ligands and upstream mediators involved in inflammasome activation. The NLRP1b inflammasome responds to lethal factor produced by *B. anthracis* and assembles an inflammasome by recruiting caspase-1 through its CARD domain or through ASC as an adaptor. The NLRP3 inflammasome responds to intracellular damage induced by pathogenic or sterile insults. The NLRC4 inflammasome assembles in response to recognition of bacterial flagellin or components of the type III secretion system via NAIPs and can form complexes with or without recruiting ASC. AIM2 inflammasome senses double-stranded DNA through its HIN200 domain. Pyrin responds to Rho modification induced by bacterial toxins. Inflammasome activation leads to caspase-1 activation that in turn cleaves its downstream effectors: the newly identified pyroptosis executioner gasdermin D and pro-form of cytokines IL-1β and IL-18. DAMP, danger associated molecular pattern; GBP, guanylate binding protein; PAMP, pathogen associated molecular pattern; T3SS, type III secretion systems.](JCB_201602089_Fig1){#fig1}

Evidence for the ability of NLRP1a to induce inflammasome activation comes from a genetic model, wherein mice harboring a mutation in the *NLRP1a* gene (Q593P) develop a caspase-1-- and IL-1β--mediated systemic inflammatory disease ([@bib97]). These mice also exhibit a change in myelopoiesis, such that the number and function of hematopoietic progenitor cells are markedly altered in a caspase-1--dependent but IL-1R signaling--independent manner. Thus, a significant loss of hematopoietic progenitors is observed because of aberrant inflammasome activation and cell-intrinsic pyroptosis. However, the specific triggers or mechanisms regulating the NLRP1a inflammasome are as yet unknown. Genetic studies in humans have identified NLRP1 mutations linked to autoinflammatory diseases including vitiligo ([@bib65]), Addison's disease ([@bib163]), rheumatoid arthritis, systemic sclerosis, and Crohn's disease ([@bib34]); however, further studies that define the molecular mechanisms and structural conformations involved in NLRP1 activation will be needed to deduce the link between NLRP1 and these autoinflammatory diseases.

NLRP3 {#s05}
=====

NLRP3 was first shown to be associated with hereditary autoinflammatory syndromes called cryopyrin-associated periodic syndromes, which are characterized by skin rashes and episodes of fever ([@bib54]). In fact, over 90 disease-associated mutations have since been observed in humans in and around the NBDs that render NLRP3 constitutively active ([@bib96]). NLRP3 is an inflammasome-forming NLR that responds to a wide range of infectious and endogenous ligands and is implicated in the pathogenesis of several autoinflammatory diseases, including arthritis, gout, diabetes, obesity, and Alzheimer's disease ([@bib45]).

The triggers that have been shown to induce NLRP3 activation include pathogen-derived ligands such as microbial cell wall components, nucleic acids, and pore-forming toxins; environmental crystalline pollutants like silica, asbestos, and alum; and endogenous danger signals like ATP, serum amyloid A, and uric acid crystals ([@bib87]). In fact, the diversity of its activators is one of the most distinctive features of the NLRP3 inflammasome and makes the possibility of a direct interaction with each activator unlikely. It is therefore assumed that the NLRP3 inflammasome either senses a common secondary activator downstream of these stimuli or responds to cellular stress associated with infection or physiological damage. Production of reactive oxygen species (ROS), potassium efflux, changes in cell volume, calcium signaling, and lysosomal disruption have all been proposed as critical upstream signals required for NLRP3 activation ([@bib22]; [@bib117]; [@bib11]; [@bib26]; [@bib49]; [@bib55]; [@bib135]; [@bib162]; [@bib20]; [@bib78]; [@bib110]; [@bib109]). Even though potassium efflux has been reported by multiple groups to be the unifying mechanism regulating NLRP3 activation, potassium efflux is also observed in response to NLRP1b activation ([@bib117]), raising doubt over the specificity of potassium efflux for NLRP3 inflammasome activation. Nevertheless, all of these features are associated with cellular stress, suggesting NLRP3 could be a global sensor of cellular damage ([Fig. 1](#fig1){ref-type="fig"}).

Although the precise trigger is unknown, recent studies have identified multiple cellular mechanisms that regulate activation of the NLRP3 inflammasome. Under resting conditions, ASC is found in the mitochondria, cytosol, and nucleus, whereas NLRP3 associates with the ER ([@bib162]). Nucleation of the inflammasome requires a change in the subcellular localization of these molecules to facilitate their interaction. This change in spatial arrangement is brought about by dynein-mediated transport of mitochondria toward the ER, bringing ASC and NLRP3 in close proximity ([@bib104]). Further, mitochondrial dysfunction induces microtubule alterations that enable the juxtaposition of NLRP3 and ASC, suggesting that diverse cellular functions involved in mitochondrial homeostasis and cytoskeletal modulations coordinate and converge on NLRP3 activation ([@bib104]). Although colocalization of inflammasome components is required for all inflammasomes to be activated, inhibitors of microtubule alterations specifically block the NLRP3 inflammasome, suggesting that distinct cytoskeletal signatures are involved in activation of certain inflammasomes ([@bib104]).

In addition to cytoskeletal rearrangements, recent studies have identified NEK7, a protein involved in cell-cycle progression, as a novel regulator of the NLRP3 inflammasome ([@bib52]; [@bib134]; [@bib140]). NEK7 is a serine/threonine kinase that is known to promote mitotic spindle formation and cytokinesis and is required for progression through mitosis ([@bib114]). NEK7 interacts with the LRR domain of NLRP3, independent of its kinase activity, and is required for NLRP3 inflammasome activation ([@bib52]). This interaction additionally restricts NLRP3 inflammasome activation to cells in interphase ([@bib140]). It was hypothesized that this cell cycle--mediated restriction of NLRP3 activation is caused by the limited cellular concentration of NEK7, such that once a cell enters mitosis, NEK7 is localized to mitotic spindles and NLRP3 activation is attenuated ([@bib140]). The significance of this intersection between NLRP3 activation and cell cycle progression is currently unknown, though it could be posited that this is a safeguard cells use to dampen the inflammasome while undergoing cell division, during which the cell may be enriched in endogenous ligands that could be misrepresented as cellular stress.

NLRC4 {#s06}
=====

NLRC4 activates procaspase-1 through its CARD domain to induce cell death ([@bib120]) in response to *Salmonella* infection ([@bib94]). Bacterial flagellin ([@bib37]; [@bib101]; [@bib105]; [@bib125]) and multiple components of the bacterial type III secretion systems ([@bib103]; [@bib161]; [@bib156]) activate the NLRC4 inflammasome, enabling it to provide host defense against a diverse range of pathogens. However, NLRC4 does not interact directly with its activators; instead, a family of proteins, termed NAIPs (NLR family, apoptosis inhibitory proteins), act as sensors that recognize the ligand and induce activation of the NLRC4 inflammasome. Mouse NAIP1 and NAIP2 recognize bacterial needle and inner rod proteins, respectively, whereas NAIP5 and NAIP6 bind to flagellin ([Fig. 1](#fig1){ref-type="fig"}; [@bib75]; [@bib161]; [@bib124]; [@bib156]). The human genome encodes only one known NAIP ([@bib30]), which can sense both flagellin and needle proteins, suggesting a similarity in the mode of recognition of the two structurally related ligands ([@bib156]; [@bib76]).

NLRC4 contains a winged-helix domain, which together with the NBD stabilizes NLRC4 in a closed conformation under basal conditions, whereas the LRR domain provides steric hindrance to its oligomerization ([@bib143]). These two inhibitory mechanisms thus maintain NLRC4 in an inactive state in the absence of a ligand. Support for this theory comes from structural modeling based on cryo-EM analysis of NAIP5-NLRC4 multimers and a crystal structure of dormant NLRC4 ([@bib23]). This study suggested that rotation of the LRR domain would be required to allow NLRC4 to fit into the active oligomeric form detected by cryo-EM ([@bib23]). A recently characterized cryo-EM structure of the NLRC4 inflammasome in response to bacterial type III secretion systems rod protein PrgJ revealed that nucleation is initiated from a single, activated NAIP2 molecule that subsequently induces NLRC4 polymerization. The inflammasome assembly follows a domino-like reaction, wherein the activated NAIP2 molecule provides a platform for self-oligomerization of NLRC4 to form a wheel- or disc-like structure ([@bib58]; [@bib160]).

In addition to removal of infected cells through pyroptosis and perpetuation of inflammation through IL-1β and IL-18 release, NLRC4 activation affects other aspects of cell biology that are critical in host defense. In macrophages infected with *Salmonella*, NLRC4 induces an actin polymerization response that prevents further bacterial uptake and increases intracellular ROS production to enhance intracellular killing and lower bacterial dissemination ([@bib90]). NLRC4 activation in epithelial cells is specifically required to control pathogen load during *Salmonella* infection. In accordance with this, epithelium-specific deletion of inflammasome components (Naip 1--6, NLRC4, and caspase-1/caspase-11) results in higher bacterial load and extraintestinal dissemination ([@bib136]). A surprising feature of NLRC4 activation is observed in a mouse model using intraperitoneal delivery of flagellin, which induces rapid host mortality (within 30 min). This striking inflammasome-dependent response is independent of IL-1β or IL-18 and instead relies on the production of eicosanoids, including prostaglandins and leukotrienes. This inflammasome-dependent eicosanoid production leads to rapid vascular fluid loss and mortality ([@bib147]). How the NLRC4 inflammasome activates biosynthesis of eicosanoids and whether this function of eicosanoid production can be extended to all inflammasomes are currently unknown. Overall, these studies highlight the importance of NLRC4 inflammasome in cellular responses beyond the conventional roles of cytokine release and pyroptosis.

Human genetic studies have identified gain-of-function mutations in NLRC4 that are associated with autoinflammation and enterocolitis ([@bib10]; [@bib74]; [@bib127]). Because NLRC4 has been ascribed such diverse functions in animal models of infection, it remains to be seen whether human patients recapitulate any specific features of NLRC4 activation.

NLRP6 {#s07}
=====

NLRP6 is uncharacteristic by virtue of the unusual ligand it recognizes and its observed downstream effects. One of the earliest studies identified NLRP6 as a negative regulator of the mitogen-activated protein kinase and NF-κB pathway in macrophages infected with *Listeria monocytogenes*, *Escherichia coli*, and *Salmonella* ([@bib2]). Thereafter, the role of NLRP6 in activation of caspase-1 was hypothesized as being required to maintain optimal mucosal response to chemical damage and pathogens ([@bib29]; [@bib152]). In the gut, NLRP6 antagonizes microbial dysbiosis through mucus production ([@bib29]). In the absence of NLRP6, the intestinal barrier integrity is compromised, rendering the animal susceptible to pathogenic and chemical insults ([@bib15]; [@bib29]; [@bib59]; [@bib57]; [@bib113]). The identity of the ligand that activates NLRP6 remained elusive until a recent study identified taurine, a microbial metabolite, as its activator ([@bib79]). The authors demonstrated that NLRP6--ASC--caspase-1 axis, through IL-18 production, promotes induction of antimicrobial peptides that resist microbial dysbiosis. The normal microbiota in turn produces a specific metabolite profile enriched in taurine that engages NLRP6 in the gut to provide mucosal immunity ([@bib79]). NLRP6 therefore has a central role in gut homeostasis and associated disorders ([@bib53]). It should be noted that altered or dysbiotic microbiota is also observed in mice lacking inflammasome sensors NLRP3 ([@bib53]) and AIM2 ([@bib93]), suggesting that the inflammasome plays a nonredundant role in maintaining gut bacterial symbiosis. The role of NLRP6 at mucosal sites is relevant even in the context of viral infection. During systemic infection with encephalomyocarditis and norovirus, NLRP6 affected viral loads specifically in the gastrointestinal tract, and oral infection with the same viruses required NLRP6-mediated defense to confer survival ([@bib148]). However, direct proof for the importance of NLRP6 at nonmucosal sites is yet to be demonstrated and further investigation is needed to uncover the molecular mechanisms governing this putative inflammasome.

NLRP12 {#s08}
======

NLRP12 was initially characterized as an inhibitor of noncanonical NF-κB signaling ([@bib150]; [@bib81]). It was also involved in caspase-1 activation in response to *Yersinia pestis* and *Plasmodium* infection ([@bib146]; [@bib3]). The role of NLRP12 in NF-κB--mediated signaling makes it an important regulator of immune response after *Salmonella* infection and during colorectal cancer ([@bib158], [@bib159]). Further, it modulates NF-κB signaling intrinsically in T cells during their activation, thereby affecting their colitogenic and encephalitogenic potential ([@bib85]). However, the ligands that activate NLRP12 and its regulatory mechanisms remain poorly understood.

ALR family {#s09}
==========

The ALR family is named for its most well-characterized member, AIM2 (absent in melanoma 2). The members of the ALR family are characterized by an N-terminal PYD and a C-terminal hematopoietic interferon-inducible nuclear protein with 200--amino acid repeat (HIN200) domain. The expression of ALRs is restricted to and conserved among mammalian species ([@bib21]). AIM2 has a distinct cytosolic localization by virtue of lacking a nuclear localization signal that is present in all other members. Further, the PYD of AIM2 is functionally distinct from other ALRs in its ability to interact with the PYD of ASC ([@bib56]). It is because of this specific interaction that AIM2 is the only member of this family known to be capable of forming an inflammasome. Other mouse ALRs have been shown to interact with ASC, making them potential regulators of inflammasome responses ([@bib7]), and another human ALR, γ-IFN--inducible protein 16, is considered a putative inflammasome ([@bib71]). However, most major studies have concerned the identification and regulation of the AIM2 inflammasome.

AIM2 {#s10}
====

AIM2 was initially identified as a γ-IFN--inducible protein in a tumor suppressor screen. A later study redefined it as a nucleic acid sensor that assembles into an inflammasome, specifically in response to double-stranded DNA (dsDNA; [Fig. 1](#fig1){ref-type="fig"}; [@bib8]; [@bib32]; [@bib56]; [@bib126]). AIM2 is critical to immune responses after infection with various viral and bacterial infectious agents, such as vaccinia virus, mouse cytomegalovirus ([@bib123]), *Francisella tularensis* ([@bib33]; [@bib66]; [@bib123]), and *Listeria* ([@bib73]; [@bib123]).

The HIN200 domain of AIM2 is involved in ligand binding and mediates dsDNA recognition, independent of sequence identity, but requires the dsDNA to be of a certain length (∼80 bp; [@bib62]). Structural and biophysical studies suggest existence of sequence-neutral electrostatic interactions between the HIN200 domain and DNA bases ([@bib62]; [@bib80]). Structural analysis also ascribes an autoinhibitory role to the HIN200 domain, because in the absence of a ligand, it interacts with the PYD of AIM2. DNA binding by the HIN200 domain relieves this autoinhibition, allowing the PYD of AIM2 to undergo homotypic interaction with the adaptor ASC ([@bib64]). Reconstituted AIM2--ASC--caspase-1 inflammasome, viewed by EM, exhibits a star-shaped structure with multiple filaments radiating from a central hub. In this complex, AIM2 and ASC form the center, whereas caspase-1 makes up the filaments ([@bib83]).

Although AIM2 binds to both viral and bacterial DNA, there is a distinct difference in their inflammasome engagement. Type I IFN signaling is required for AIM2 activation in response to bacterial stimuli, such as *Francisella*, but not viral stimuli, like mouse cytomegalovirus ([@bib92]; [@bib100]). Type I IFN signaling induces expression of IFN regulatory genes that mediate bacterial cytosolic escape and bacterial lysis, releasing the ligand for AIM2 activation ([@bib92]; [@bib100]). Despite the ubiquitous nature of this ligand, not all bacteria and viruses activate the AIM2 inflammasome. Recent studies indicate that certain bacteria, such as *Mycobacterium* and *Legionella*, encode virulence factors that can reduce dsDNA release and thereby evade detection by AIM2 ([@bib115]; [@bib41]; [@bib137]). The AIM2 inflammasome is also inhibited by host-encoded decoy molecules and dominant-negative regulators ([@bib25]; [@bib108]; [@bib72]). Another member of the HIN200 family, p202, lacks the N-terminal PYD and acts as a negative regulator of the AIM2 inflammasome, perhaps by sequestering dsDNA and/or AIM2 through heterodimerization ([@bib126]; [@bib157]). Recognition of nucleic acids also grants AIM2 the ability to respond to host DNA released in response to cellular damage. This recognition and the ensuing inflammasome activation underlie various autoinflammatory diseases, such as psoriasis, systemic lupus erythematosus, and abdominal aortic aneurysm ([@bib25]; [@bib18]; [@bib24]), raising the possibility of AIM2 as a therapeutic target for these autoimmune disorders.

Pyrin {#s11}
=====

Pyrin is associated with an autoinflammatory disorder called familial Mediterranean fever and was only recently identified as an inflammasome-forming protein. Pyrin was first implicated in inflammasome activation from a mouse model expressing familial Mediterranean fever mutation--containing pyrin; these mice exhibited an ASC and IL-1--mediated autoinflammatory disorder ([@bib13]). A more recent study provided definitive proof by showing that the pyrin inflammasome assembles in response to Rho-modifying toxins produced by various bacterial species, including *Clostridium difficile* (TcdB), *Vibrio parahemolyticus* (VopS), *Histophilus somni* (IbpA), *Clostridium botulinum* (C3), and *Burkholderia cenocepacia* ([Fig. 1](#fig1){ref-type="fig"}; [@bib154]). These toxins induce covalent modifications that include glycosylation, adenylylation, and ADP ribosylation within the Switch I region of Rho family members, suggesting a universal signature detected by the pyrin inflammasome. In another study, pertussis toxin, through its ADP-ribosyltransferase activity, was shown to engage the pyrin inflammasome ([@bib27]). Although a direct interaction between Rho and pyrin has not been detected, Rho modification seems to be essential for pyrin inflammasome activation, suggesting that pyrin responds to the functional activity of Rho. However, the consequence of Rho modification and the intermediary steps involved in pyrin activation are currently unknown. As Rho modifications are closely associated with multiple cellular functions, including division and migration, pyrin activation is likely kept in check during these processes. A recent study identified 14-3-3 proteins as regulators of pyrin activity until a pyrin-activating stimuli releases pyrin from this inhibition ([@bib98]). Pyrin phosphorylation targets 14-3-3 for binding under basal conditions and dephosphorylation attenuates 14-3-3 binding. Further, a human mutation in this phosphosite recapitulates pyrin activation, even in the absence of an exogenous stimuli ([@bib98]). The molecular regulators controlling pyrin phosphorylation and dephosphorylation are still being elucidated. 14-3-3 proteins are critical scaffolds involved in cell cycle progression and cell death, so it remains to be seen whether 14-3-3 interaction forms a nexus between these cellular processes and pyrin activation.

ASC oligomerization and the "ASC speck" {#s12}
=======================================

The interaction between major inflammasome components occurs through homotypic PYD--PYD or CARD--CARD interactions. The PYD and CARD domains possess nucleating ability that allows them to induce oligomerization, forming the structural basis for assembly of inflammasomes ([@bib9]; [@bib83]; [@bib132]). Based on these domains, inflammasome sensors assemble into complexes with or without the adaptor ASC. CARD-containing NLRP1 and NLRC4 directly recruit caspase-1 ([@bib112]; [@bib63]; [@bib119]), whereas PYD-containing NLRP3, AIM2, and pyrin recruit ASC for inflammasome assembly. Even though NLRP1 and NLRC4 can induce pyroptosis in an ASC-independent manner, efficient cytokine processing depends on ASC-mediated supramolecular complex assembly ([@bib94]; [@bib6]; [@bib44]; [@bib144]). Because of the homotypic interactions underlying inflammasome assembly, pyrin-only proteins and CARD-only proteins can act as dominant-negative regulators to block transduction of inflammasome signaling ([@bib99]).

ASC-dependent NLRP3 and AIM2 activation have been recapitulated in vitro and proceeds through two subsequent nucleation events. First, the sensor nucleates ASC to form oligomeric filaments. Second, ASC nucleates caspase-1, such that the sensor, the adaptor, and the enzyme are present at increasing concentrations within the larger complex to effectuate signal amplification ([@bib83]). ASC specks generated in response to inflammasome activation can be visualized as micrometer-sized foci and can be recapitulated in vitro. Under physiological pH, ASC assembles into filaments through electrostatic and hydrophobic interactions among the PYD domains, as observed by nuclear magnetic resonance spectroscopy and cryo-EM ([@bib107]; [@bib132]). The CARD domain in these filaments is dynamic to facilitate interaction with the CARD domain of caspase-1. Mutational studies pinpointed multiple interacting surfaces between ASC--CARD and caspase-1--CARD, and inflammasome activity is dependent on these interfaces ([@bib121]). Although large strides have been made in determining the structural features of inflammasomes, the architecture of the inflammasome in intact cells remains unresolved.

Activation of inflammasome is an all-or-none phenomenon ([@bib82]), and a pathogen can simultaneously engage multiple inflammasome sensors within a single cell ([@bib5]; [@bib91]; [@bib68]). It is notable that irrespective of activation of multiple inflammasomes, they all converge on a single supramolecular structure and ASC speck per cell ([@bib5]; [@bib91]; [@bib68]). It was recently demonstrated that in response to *Salmonella* infection, NLRC4 recruits NLRP3 and ASC to promote inflammasome activation, highlighting crosstalk between the inflammasome sensors ([@bib122]). *Salmonella* activates NLRP3 and NLRC4 through distinct stimuli ([@bib5]), so it remains to be seen how and at what stage these signals are integrated. It is possible that the two sensors, once in close proximity, somehow interact and merge to form one complex, though this remains to be confirmed through direct visualization of such events.

In addition to driving pyroptosis and cytokine maturation, inflammasome activation leads to release of ASC specks that are phagocytosed by adjacent cells. This drives ASC nucleation, demonstrating the ability of specks to act as inflammasome-perpetuating signals in recipient cells ([@bib4]; [@bib38]). Given the ability of PYD and CARD domains to assemble into filamentous structures, the initial nucleation event might allow an ASC speck to act as a scaffold for addition of soluble ASC monomers, via a prionic, self-propagating mechanism ([@bib17]; [@bib9]; [@bib38]). Thus, the ASC speck can potentiate inflammation by amplifying the inflammasome response through multiple mechanisms ([Fig. 2](#fig2){ref-type="fig"}).

![**ASC-mediated amplification of inflammasome activation.** ASC mediates amplification of inflammasome signals through at least three distinct mechanisms. (1) Signal transduction during inflammasome assembly, such that the sensor, ASC, and caspase-1 are present at increasing concentrations and each sensor activates a much greater number of the enzyme molecules. (2) Caspase-1--mediated maturation and release of bioactive cytokines affects activation and further infiltration of immune cells, eventually amplifying the overall inflammatory response. (3) The released ASC speck can be taken up by neighboring cells and promotes ASC assembly in the recipient cells, consequently providing another mode of inflammasome amplification.](JCB_201602089_Fig2){#fig2}

Caspase-11 and the NLRP3 inflammasome {#s13}
=====================================

Caspase-11 is an inflammatory caspase identified as a binding partner and mediator of caspase-1 activation ([@bib149]). The functional significance of caspase-11 was masked for a long time because of its high genetic linkage to caspase-1 ([@bib69]). It was eventually identified as an inducer of pyroptosis independent of caspase-1 and was further required for NLRP3 inflammasome activation specifically in response to gram-negative bacteria through its CARD domain ([@bib141]). Caspase-11 acts as both the sensor and the inducer of lipopolysaccharide (LPS)-induced pyroptotic responses and further triggers assembly of the NLRP3 inflammasome. This distinguishes the two functions of inflammasome activation, such that pyroptosis proceeds through activation of caspase-11, whereas cytokine processing occurs through NLRP3-mediated caspase-1 activation ([Fig. 3](#fig3){ref-type="fig"}).

![**Caspase-11--regulated NLRP3 inflammasome.** The NLRP3 inflammasome can be assembled in response to caspase-11--mediated recognition of cytosolic LPS. The up-regulation of caspase-11 and induction of guanylate binding proteins (GBPs), involved in vacuolar lysis for LPS release, is mediated through a TLR4--TRIF--type I IFN signaling module. Caspase-11 directly cleaves gasdermin D to induce pyroptosis and activate NLRP3 through an as-of-yet-unknown mechanism.](JCB_201602089_Fig4){#fig3}

How caspase-11 promotes the noncanonical NLRP3 activation is not entirely known. Although caspase-11 can interact with caspase-1 ([@bib149]), loss of caspase-11 does not affect canonical NLRP3--ASC complex assembly, disproving its role as an essential adaptor. Another possibility is that caspase-11 employs a downstream molecule to instigate NLRP3 inflammasome assembly. For example, caspase-11 activation causes a drop in intracellular potassium levels, suggesting that potassium efflux could bridge caspase-11 and NLRP3 activation ([@bib128]; [@bib133]). Pannexin-1 is also a caspase-11 target, and pannexin-1 cleavage induces activation of the NLRP3 inflammasome through a drop in intracellular potassium levels ([@bib155]). However, the specificity of potassium efflux to NLRP3 activation has not been established ([@bib117]), so it remains to be seen whether intracellular potassium is the exclusive link between caspase-11 and NLRP3 activation.

Pyroptosis and GSDMD {#s14}
====================

Inflammasome activation leads to a distinct form of programmed cell death termed pyroptosis, characterized by cellular lysis, release of intracellular components, and an inflammatory response. To date, caspase-induced pyroptosis has been demonstrated in macrophages ([@bib36]), dendritic cells ([@bib28]), enterocytes ([@bib136]), and hematopoietic progenitors ([@bib97]), whereas neutrophils and monocytes do not undergo pyroptosis after inflammasome activation ([@bib102]; [@bib16]; [@bib40]). Pyroptosis also appears to be evolutionarily conserved, as loss of macrophages caused by pyroptosis has been visualized in zebrafish larvae after *Listeria* infection, marked by ASC speck and nuclear condensation ([@bib145]). Pyroptosis is therefore a critical feature of inflammasome activation in a wide variety of cells.

Pyroptosis is a distinct form of cell death but shares certain features with both apoptosis and necrosis. Similar to necrosis, pyroptosis involves the formation of 1- to 2-nm pores on the cell membrane ([@bib35]). It further proceeds through cytoplasmic swelling, osmotic lysis, and release of intracellular contents. Similar to apoptosis are the features of nuclear condensation and DNA damage ([@bib106]; [@bib35]; [@bib77]). Furthermore, processing of executioner caspase-3 and -7 is observed in both apoptosis and pyroptosis ([@bib77]; [@bib1]), though it is important to note that, during pyroptosis, membrane permeabilization and DNA fragmentation can occur even in the absence of executioner caspases. These studies highlight both the similarities and distinctions in these cell death pathways.

Until recently the mediators driving cell death after caspase-1 or caspase-11 activation were completely unknown. Although caspase-7 was identified as a caspase-1 target ([@bib77]; [@bib1]), pyroptosis can occur independently of executioner caspases, ruling out its role in pyroptosis. A missing link between caspase-1 activation and pyroptosis was later identified as GSDMD by three independent groups ([@bib51]; [@bib70]; [@bib142]). GSDMD was found to be a direct target of inflammatory caspase-1, caspase-4, and caspase-11 and is essential for pyroptosis and IL-1β release after inflammasome activation ([@bib70]; [@bib142]). Caspase-1, -4, -5, and -11 recognize and cleave GSDMD at the same site ([@bib70]; [@bib142]). GSDMD cleavage is required for its activity, and the N terminus is sufficient to induce pyroptosis, suggestive of an autoinhibitory role for the GSDMD C terminus ([@bib142]). These studies highlight the importance of GSDMD as a critical inducer of pyroptosis and provide one of the missing links between activation of inflammatory caspases and cell death. These studies also shed light on the process of IL-1β secretion; although maturation is caspase-1 dependent, release requires pyroptosis ([@bib51]; [@bib70]; [@bib142]). This idea of dying cells as the major source of secreted IL-1β was put forth and demonstrated in another study that characterized caspase-1 activation as an all-or-none signal ([@bib82]). However, how GSDMD executes cell death is still not known. Nevertheless, identification of GSDMD will now allow investigators to assess the physiological relevance of pyroptosis independent of other aspects of inflammasome activation.

Caspase-8 and inflammasomes {#s15}
===========================

Although caspase-8 has long been considered to be in the domain of apoptosis, recent studies have highlighted its contribution to inflammasome activation, IL-1β production, and cell death in response to a range of ligands. Fungal, mycobacterial, or β-glycan recognition through dectin-1 induces caspase-8--dependent IL-1β processing ([@bib43]) via a complex composed of caspase-8, MALT1, and ASC ([@bib43]). Although this complex employs the inflammasome adaptor ASC and leads to processing of IL-1β, a typical inflammasome readout, it does not proceed through activation of inflammatory caspase-1 or caspase-11. For this reason, it is not widely accepted as an inflammasome platform ([@bib88]). In response to NLRC4 activation by *Salmonella*, caspase-8 is recruited to the inflammasome via ASC and contributes to IL-1β processing ([@bib89]). Caspase-8 was also shown to have a role in both priming and activation of the NLRP3 inflammasome ([@bib47]). This role for caspase-8 in mediating inflammasome activation is supported by another study in which caspase-8 inhibition reduced NLRP3 and AIM2-induced caspase-1 activation ([@bib153]). Caspase-8 additionally acts in concert with NLRP3 inflammasome to drive IL-1β--mediated osteomyelitis in *PSTPIP2cmo* mice ([@bib84]; [@bib48]). ASC-mediated caspase-8 recruitment and activation additionally leads to apoptosis in response to AIM2 and NLRP3 activation. This study proposed that although pyroptosis is a rapid form of cell death, cells lacking caspase-1 undergo caspase-8--mediated apoptosis induced with delayed kinetics ([@bib130]). This ASC/caspase-8--mediated apoptosis in response to AIM2 stimulation is also observed in response to *Francisella* infection ([@bib118]). Even though caspase-8 is known to be a determinant of cell survival or cell death through apoptosis, these studies have ascribed a pivotal role for caspase-8 in inflammasome activation.

Autophagy and inflammasomes {#s16}
===========================

Autophagy involves the degradation of damaged organelles and recycling of cellular metabolites. Inflammasomes, on the other hand, respond to stimuli that mark cellular damage through aberrant physiological functions or in response to infectious agents. The intersection of these two cellular responses is therefore inevitable and critical to the maintenance of cellular physiology. Cells activate autophagy in response to a pathogenic insult to contain the infection and promote clearance of the pathogen ([@bib139]). Autophagy also clears damaged organelles generated as a byproduct of homeostatic or activatory conditions ([@bib61]) and thereby attenuates the inflammasome response. Mechanisms so far identified to mediate inflammasome inhibition via autophagy include the dampening of ROS production ([@bib162]; [@bib86]), removal of damaged mitochondria ([@bib61]), degradation of ASC aggregates ([@bib139]), and sequestration of pro--IL-1β ([@bib50]). Conversely, blocking autophagy promotes inflammasome activation through accumulation of ROS-generating mitochondria ([@bib162]; [@bib61]). Further, cells lacking components of autophagosome assembly, such as ATG16L, LC3B, and beclin-1 ([@bib131]; [@bib111]), show increased inflammasome activation. In addition, IL-1β promotes autophagy, highlighting a negative feedback mechanism for inflammasome activation ([@bib116]).

Conversely, autophagy can be regulated by inflammasome components. NLRP3 and NLRC4 can interact with beclin 1, an important regulator of autophagy. Association with NLRC4 inhibits autophagy under both physiological conditions and bacterial infection. NLRC4 additionally interacts with the class C vacuolar protein-sorting complex and inhibits autophagosome maturation ([@bib67]). Caspase-1 activation can also inhibit autophagy in response to inflammasome activation after bacterial stimuli. Toll/Interleukin receptor domain-containing adapter-inducing interferon β (TRIF) is a caspase-1 substrate, such that caspase-1 activation reduces TRIF-dependent type I IFN--mediated autophagy ([@bib60]). The functional consequence of this modulation is not entirely known and seems to be a mechanism to amplify the inflammatory response by blocking autophagy-mediated bacterial clearance and removal of endogenous inflammasome activators. In addition to autophagy, inflammasome activation can affect other physiological processes associated with cellular metabolism. Glycolytic enzymes are direct caspase-1 substrates, and reduced glycolytic flux is observed in response to inflammasome activation ([@bib138]). Inflammasome activation additionally induces lipid synthesis and membrane biogenesis through activation of sterol regulatory element binding proteins ([@bib46]). This serves as a means to promote cell membrane repair and consequent cell survival.

These studies highlight that inflammasome activation controls multiple processes involved in cellular biology. In addition to inducing cell death, caspase-1 activation affects signals regulating cell metabolism and survival. It is tempting to hypothesize that in response to a cellular stress, multiple signaling modules are affected, including pyroptosis/apoptosis and cellular metabolism, such that based on the degree of damage, the overall fate of the affected cell could be repair or death.

Conclusion and future directions {#s17}
================================

Inflammasome activation is intricately intertwined with basic cellular functions. In addition to removal of damaged cells, inflammasomes are also involved in cell repair, metabolism, and proliferation. Various molecules believed to be involved in the maintenance of cellular homeostasis have been demonstrated to act as critical regulators of inflammasome function and vice versa. Newly uncovered functions for the inflammasome in cell metabolism and proliferation require further investigation. In addition, several questions still remain: What are the endogenous triggers of inflammasome activation, and how are they generated during physiological processes? What is the link between cell division and inflammasome activation? What regulates inflammasome assembly in response to multiple-sensor activation to permit one ASC speck per cell? What are the cytoskeletal changes involved in inflammasome activation, and how are they brought about? What are the molecules involved in GSDMD-mediated cell rupture? What regulates the crosstalk between different cell death mechanisms? Investigating these and other research avenues highlighted in this review will expand our current understanding of the cell biology of inflammasomes and fuel the interest of the research community for years to come.
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